Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
NCT02748395 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2016-12-05
Summary
The purpose of this study is to determine whether the injection of triamcinolone and lidocaine is effective in relieving chronic abdominal wall pain.
Conditions
- Chronic Abdominal Wall Pain
- Abdominal Cutaneous Nerve Entrapment Syndrome
Interventions
- DRUG
-
Triamcinolone
- OTHER
-
Placebo
- DRUG
-
Lidocaine
Sponsors & Collaborators
-
Temple University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2016-12-31
More Related Trials
-
Neuropathic Pain Caused by Radiation Therapy
NCT00798083 ·Status: COMPLETED ·Phase: PHASE3
-
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
NCT05864053 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Steroids Versus Gabapentin
NCT01495923 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain
NCT02024724 ·Status: COMPLETED ·Phase: PHASE4
-
Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment
NCT03348735 ·Status: TERMINATED ·Phase: PHASE4
-
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
NCT00058357 ·Status: COMPLETED ·Phase: PHASE3
-
Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women
NCT06080828 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia
NCT02801630 ·Status: UNKNOWN ·Phase: NA
-
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
NCT07122453 ·Status: RECRUITING ·Phase: PHASE1
-
Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)
NCT00916942 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
NCT01096966 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tanezumab in Adults With Chronic Low Back Pain
NCT00876187 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Pain in Spinal Cord Injury
NCT00006428 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
NCT01087203 ·Status: TERMINATED ·Phase: PHASE2
-
Ketamine HCl Prolonged Release Oral Tablets for CRPS
NCT06419985 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Transient Receptor Potential Channels
NCT06444594 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
NCT03070132 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Significance of Peripheral Input
NCT04764045 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain
NCT01345045 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain
NCT01020162 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
NCT02643251 ·Status: COMPLETED ·Phase: PHASE2
-
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
NCT02473016 ·Status: COMPLETED ·Phase: PHASE2
-
Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome
NCT01920880 ·Status: COMPLETED
-
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
NCT01086150 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy
NCT01589432 ·Status: COMPLETED ·Phase: PHASE2